Back
Mirati Therapeutics Stock Price Chart
Your Financial Advisor Doesn't Even Realize This Could Happen
Watch the free video
Sell
27
MRTX
Mirati Therapeutics
Last Price:
57.04
Seasonality Move:
10.63%
7 Day Trial
ALL ACCESS PASS
$
7
Serious profits in months with teeny tiny gains?
Check out the details here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Mirati Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.81 | Buy |
| 20-day SMA: | 56.47 | Buy |
| 50-day SMA: | 53.93 | Buy |
| 200-day SMA: | 42.75 | Buy |
| 8-day EMA: | 56.8 | Buy |
| 20-day EMA: | 56.27 | Buy |
| 50-day EMA: | 52.79 | Buy |
| 200-day EMA: | 48.49 | Buy |
Mirati Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.94 | Buy |
| Relative Strength Index (14 RSI): | 65.66 | Buy |
| Chaikin Money Flow: | 549176 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.86 - 56.76) | Buy |
| Bollinger Bands (100): | (33.47 - 54.97) | Buy |
Mirati Therapeutics Technical Analysis
| Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 17 | 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mirati Therapeutics Stock
Is Mirati Therapeutics Stock a Buy?
- Mirati Therapeutics share price is 57.08 while MRTX 8-day simple moving average is 56.81, which is a Buy signal.
- The stock price of MRTX is 57.08 while Mirati Therapeutics 20-day SMA is 56.47, which makes it a Buy.
- Mirati Therapeutics 50-day simple moving average is 53.93 while MRTX share price is 57.08, making it a Buy technically.
- MRTX stock price is 57.08 and Mirati Therapeutics 200-day simple moving average is 42.75, creating a Buy signal.
MRTX Technical Analysis vs Fundamental Analysis
Sell
27
Mirati Therapeutics (MRTX)
is a Sell
Is Mirati Therapeutics a Buy or a Sell?
-
Mirati Therapeutics stock is rated a Sell
The current Mirati Therapeutics [MRTX] share price is $57.08. The Score for MRTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Mirati Therapeutics Stock Info
Market Cap:
4B
Price in USD:
57.08
Share Volume:
854.27K
Mirati Therapeutics 52-Week Range
52-Week High:
96.58
52-Week Low:
27.30
Sell
27
Mirati Therapeutics (MRTX)
is a Sell
Mirati Therapeutics Share Price Forecast
-
What is the Mirati Therapeutics stock price today?
The Mirati Therapeutics stock price is 57.08 USD today. -
Will MRTX stock go up or go down?
Mirati Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Mirati Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mirati Therapeutics is overvalued.
Is Mirati Therapeutics Stock a Buy?
- Mirati Therapeutics share price is 57.08 while MRTX 8-day exponential moving average is 56.80, which is a Buy signal.
- The stock price of MRTX is 57.08 while Mirati Therapeutics 20-day EMA is 56.27, which makes it a Buy.
- Mirati Therapeutics 50-day exponential moving average is 52.79 while MRTX share price is 57.08, making it a Buy technically.
- MRTX stock price is 57.08 and Mirati Therapeutics 200-day simple moving average is 48.49, creating a Buy signal.
Fundamental Analysis of Mirati Therapeutics
Is Mirati Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.94 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.20 per share, and an increase next year of $1.18 per share.
Technical Analysis of Mirati Therapeutics
Should I short Mirati Therapeutics stock?
- MRTX Moving Average Covergence Divergence (MACD) indicator is 0.94, suggesting Mirati Therapeutics is a Buy
- Mirati Therapeutics Relative Strength Index (RSI) is 65.66, which suggest Mirati Therapeutics is overbought
- The Bollinger Bands (25) for Mirati Therapeutics is (55.86 - 56.76), which suggest Mirati Therapeutics is a Buy
- The Bollinger Bands (100) for Mirati Therapeutics is (33.47 - 54.97), which suggest Mirati Therapeutics is a Buy
* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.